This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. (December 2018) |
Mark Rasenick is an American biologist focusing on G protein signaling in the nervous system, the relationship of neurotransmitter activation to rapid modification of the cytoskeleton, how G proteins and the cytoskeleton work in concert to modify synaptic shape and form a molecular basis for depression and the action of antidepressant drugs.
Mark Rasenick | |
|---|---|
| Nationality | American |
| Scientific career | |
| Fields | Biology |
Rasenick works at the University of Illinois, and is an Elected Fellow of the American Association for the Advancement of Science. He has made significant contributions towards advancing the understanding of neurotransmitter signaling and the biology of mood disorders, and his research helped identify a membrane protein, the localization of which can be used as a biomarker for depression.[1][2][3]
References
edit- ^ "Mark Rasenick". aaas.org. Retrieved May 14, 2017.
- ^ "Mark Rasenick". uic.edu. Retrieved May 14, 2017.
- ^ "Mark Rasenick". uic.edu. Retrieved May 14, 2017.
This article about a biologist from the United States is a stub. You can help Wikipedia by expanding it. |